Price$21.86+0.04 (+0.16%)
01:30 PM07:45 PM
News · 26 weeks35+183%
2025-12-072026-05-31
Mix2790d
- Insider15(56%)
- SEC Filings7(26%)
- Other3(11%)
- Earnings2(7%)
Latest news
25 items- INSIDEREVP, CFO and Treasurer Rossi Kasandra H was granted 31,800 shares and covered exercise/tax liability with 3,701 shares, increasing direct ownership by 38% to 101,399 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERChief Executive Officer Ordan Mark S was granted 224,372 shares, covered exercise/tax liability with 19,119 shares and returned 97,174 shares to the company, increasing direct ownership by 36% to 410,884 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDEREVP, Chief Invest & Strategy Neeb Don Gregory covered exercise/tax liability with 8,003 shares and was granted 63,888 shares, increasing direct ownership by 69% to 137,231 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDEREVP, GC, Chief Admin Off & Sec Moore Mary Ann E covered exercise/tax liability with 11,944 shares, decreasing direct ownership by 11% to 96,466 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- PRPediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in NeonatologyResearch Was Conducted Utilizing the Proprietary Pediatrix Clinical Data Warehouse Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced the publication of new research on probiotic use and necrotizing enterocolitis (NEC) in preterm infants, addressing pressing questions about one of the most controversial issues in the field of neonatology. The research was conducted by clinicians affiliated with the Pediatrix Center for Research, Education, Quality and Safety in collaboration with the NEC Society, utilizing data from the Pediatrix Clinical Data Warehouse (CDW), one of the largest databases of neonatal outcomes in the world. Data from the Ped
- SECSEC Form S-8 filed by Pediatrix Medical Group Inc.S-8 - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- INSIDERDirector Weis Shirley A sold $855,665 worth of shares (36,028 units at $23.75) (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Mceachin Thomas gifted 11,427 shares and received a gift of 11,427 shares, decreasing direct ownership by 61% to 7,196 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDEREVP, GC, Chief Admin Off & Sec Moore Mary Ann E gifted 40,826 shares, decreasing direct ownership by 27% to 108,410 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Rucker Michael A. was granted 7,196 shares, increasing direct ownership by 12% to 66,297 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Linynsky Laura A was granted 7,196 shares, increasing direct ownership by 22% to 39,428 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Sansone Guy P was granted 7,196 shares, increasing direct ownership by 9% to 86,944 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Young Sylvia Jean was granted 7,196 shares, increasing direct ownership by 18% to 47,814 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Starcher John M. Jr. was granted 7,196 shares, increasing direct ownership by 11% to 73,260 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Weis Shirley A was granted 7,196 shares, increasing direct ownership by 63% to 18,623 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Mceachin Thomas was granted 7,196 shares, increasing direct ownership by 63% to 18,623 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Newman Kurt Douglas was granted 7,196 shares, increasing direct ownership by 74% to 16,933 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- SECPediatrix Medical Group Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- SECSEC Form 10-Q filed by Pediatrix Medical Group Inc.10-Q - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- SECPediatrix Medical Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- PRPediatrix Medical Group Reports First Quarter ResultsPediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended March 31, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.44. For the 2026 first quarter, Pediatrix reported the following results: Net revenue of $476 million; Net income of $30 million; and Adjusted EBITDA of $58 million. "Our first quarter operating results exceeded our expectations, driven by top-line growth," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "Our priorities for 2026 remain focused on maximizing quality driven support for our hospital partners. With robust cash flow a
- PRPediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 5, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2026. A detailed press release will be issued the morning of May 5, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. About Pediatrix Medical Group Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children acr
- SECSEC Form DEFA14A filed by Pediatrix Medical Group Inc.DEFA14A - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- SECSEC Form DEFA14A filed by Pediatrix Medical Group Inc.DEFA14A - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- SECSEC Form DEF 14A filed by Pediatrix Medical Group Inc.DEF 14A - Pediatrix Medical Group, Inc. (0000893949) (Filer)
MD FAQ
6 questionsWhat does Pediatrix Medical Group Inc. do?
MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated...Where does MD stock trade?
Pediatrix Medical Group Inc. (MD) is listed on NYSE.What sector and industry is MD in?
Pediatrix Medical Group Inc. operates in the Health Care sector, Hospital/Nursing Management industry.What are analysts saying about MD?
Pediatrix Medical Group Inc. has had 8 recent analyst actions on file. The most recent action was from Macquarie: Outperform on 2024-12-16. Recent price targets range from $800.00 to $3200.00.What companies are similar to MD?
Notable peers in the same industry include HCA (HCA Healthcare Inc.), THC (Tenet Healthcare Corporation), EHC (Encompass Health Corporation), ENSG (The Ensign Group Inc.), UHS (Universal Health Services Inc.). Compare MD side-by-side with any of them on Quantisnow.How can I track MD on Quantisnow?
Quantisnow aggregates Pediatrix Medical Group Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MD to receive live email and push alerts on every new disclosure.